Items for Author "Chang, GC"
Return to Browse by Author
Showing 34 items.
Collection |
Date |
Title |
Authors |
Bitstream |
[中山醫學大學研究成果] 其他文獻 |
2021 |
Efficacy of Lorlatinib in Treatment-Naive Patients (pts) With ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in Relation to EML4-ALK Variant Type and ALK Mutations. |
Bearz, A; Martini, JF; Jassem, J; Kim, SW; Chang, GC; Shaw, A; Shepard, D; Dall'O', E; Polli, A; Thurm, H; Zalcman, G; Campelo, MRG; Penkov, K; Hayashi, H; Solomon, BJ |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Sub-multiplicative interaction between polygenic risk score and household coal use in relation to lung adenocarcinoma among never-smoking women in Asia |
Blechter, B; Wong, JYY; Hsiung, CA; Hosgood, HD; Yin, ZH; Shu, XO; Zhang, H; Shi, JX; Song, L; Song, MS; Zheng, W; Wang, ZM; Caporaso, N; Burdette, L; Yeager, M; Berndt, SI; Landi, MT; Chen, CJ; Chang, GC; Hsiao, CF; Tsai, YH; Chen, KY; Huang, MS; Su, WC; Chen, YM; Chien, LH; Chen, CH; Yang, TY; Wang, CL; Hung, JY; Lin, CC; Perng, RP; Chen, CY; Chen, KC; Li, YJ; Yu, CJ; Chen, YS; Chen, YH; Tsai, FY; Seow, WJ; Bassig, BA; Hu, W; Ji, BT; Wu, W; Guan, P; He, QC; Gao, YT; Cai, QY; Chow, WH; Xiang, YB; Lin, DX; Wu, C; Wu, YL; Shin, MH; Hong, YC; Matsuo, K; Chen, KX; Wong, MP; Lu, DR; Jin, L; Wang, JC; Seow, A; Wu, TC; Shen, HB; Fraumeni, JF; Yang, PC; Chang, IS; Zhou, BS; Chanock, SJ; Rothman, N; Chatterjee, N; Lan, Q |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations |
Chang, GC; Lam, DCL; Tsai, CM; Chen, YM; Shih, JY; Aggarwal, S; Wang, SH; Kim, SW; Kim, YC; Wahid, I; Li, RB; Lim, DWT; Sriuranpong, V; Chan, RTT; Lorence, RM; Carriere, P; Raabe, C; Cseh, A; Park, K |
|
[中山醫學大學研究成果] 期刊論文 |
2020 |
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients |
Chang, GC; Yang, TY; Chen, KC; Hsu, KH; Huang, YH; Su, KY; Yu, SL; Tseng, JS |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies |
Chen, EY; Huang, YH; Chen, YM; Chen, ER; Yang, SY; Chang, GC; Tang, KT |
|
[中山醫學大學研究成果] 期刊論文 |
2020 |
RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer |
Chen, MC; Chen, KC; Chang, GC; Lin, H; Wu, CC; Kao, WH; Teng, CLJ; Hsu, SL; Yang, TY |
|
[中山醫學大學研究成果] 期刊論文 |
2020 |
Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model |
Chien, LH; Chen, CH; Chen, TY; Chang, GC; Tsai, YH; Hsiao, CF; Chen, KY; Su, WC; Wang, WC; Huang, MS; Chen, YM; Chen, CY; Liang, SK; Chen, CY; Wang, CL; Lee, MH; Chung, RH; Tsai, FY; Hu, JW; Katki, HA; Chatterjee, N; Chanock, SJ; Rothman, N; Lan, Q; Yang, PC; Chen, CJ; Chang, IS; Hsiung, CA |
|
[醫學檢驗暨生物技術學系暨碩士班] 期刊論文 |
2006 |
Association of TNF-α Polymorphism with Susceptibility to and Severity of Non-Small Cell Lung Cancer |
Chuen-Ming Shih; Yao-Ling Lee; Hui-Ling Chiou; Wei Chen; Gee-Chen Chang; Ming-Chih Chou; Long-Yau Lin |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naive Advanced EGFR-Mutant Lung Adenocarcinoma Patients |
Hsu, KH; Huang, JW; Tseng, JS; Chen, KW; Weng, YC; Yu, SL; Yang, TY; Huang, YH; Chen, JJ; Chen, KC; Chang, GC |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study |
Huang, YH; Hung, JY; Ko, HW; Su, PL; Lai, CL; Chang, HC; Hsia, TC; Lin, SH; Wu, KL; Yang, CT; Su, WC; Chu, YC; Wang, CC; Liao, WY; Lin, YT; Lin, CH; Lin, MC; Hsu, KH; Tseng, JS; Yang, TY; Chen, KC; Lee, MH; Yu, SL; Ho, CC; Chang, GC |
|
[中山醫學大學研究成果] 期刊論文 |
2020 |
Antiplatelet agents and anticoagulants increased the bleeding risk of bedside percutaneous dilational tracheostomy in critically ill patients |
Huang, YH; Tseng, CH; Chan, MC; Lee, BJ; Lin, CH; Chang, GC |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M |
Huang, YH; Tseng, JS; Hsu, KH; Chen, KC; Su, KY; Yu, SL; Chen, JJW; Yang, TY; Chang, GC |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Transformations First Into Squamous-Cell Carcinoma and Later Into Sarcomatoid Carcinoma After Acquired Resistance to Osimertinib in a Patient With EGFR-Mutant Lung Adenocarcinoma: Case Report |
Lee, PH; Chang, GC |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non-small cell lung cancer patients |
Lee, PH; Chen, KC; Hsu, KH; Huang, YH; Tseng, JS; Yang, TY; Chang, GC |
|
[中山醫學大學研究成果] 其他文獻 |
2020 |
Hepatitis B flare during osimertinib targeted therapy in a lung cancer patient with a resolved hepatitis B virus infection |
Lee, PH; Lee, TY; Chang, GC |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors |
Lee, PH; Yang, TY; Chen, KC; Huang, YH; Jeng-Sen Tseng; Hsu, KH; Wu, YC; Liu, KJ; Chang, GC |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts |
Lee, PJ; Ho, CC; Ho, H; Chen, WJ; Lin, CH; Lai, YH; Juan, YC; Chu, WC; Lee, JH; Su, SF; Chen, HY; Chen, JJW; Chang, GC; Li, KC; Yang, PC; Chen, HW |
|
[醫學檢驗暨生物技術學系暨碩士班] 期刊論文 |
2004-11 |
Alteration of autoantibodies against p53 in Taiwanese lung cancer patients undergoing chemotherapy. |
Lee YL; Shih CM; Chiou HL; Shiau MY; Chang GC; Chang YH |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers |
Liang, SK; Chien, LH; Chang, GC; Tsai, YH; Su, WC; Chen, YM; Huang, MS; Lin, HC; Fang, WT; Hung, HH; Jiang, SS; Chen, CY; Chen, KY; Chang, IS; Hsiung, CA; Chen, CJ; Yang, PC |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Long-Term Survival Effect of the Interval between Postoperative Chemotherapy and Radiotherapy in Patients with Completely Resected Pathological N2 Non-Small-Cell Lung Cancer |
Lin, SM; Ku, HY; Hsu, CY; Wang, CL; Chang, GC; Chang, CS; Liu, TW |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Phase I results of S49076 plus gefitinib in patients with EGFR TKI-resistant non-small cell lung cancer harbouring MET/AXL dysregulation |
Park, K; Chang, GC; Curigliano, G; Lim, WT; Soo, RA; Molina-Vila, MA; Cattan, V; Darville, H; Gandossi, E; Smutna, V; Sudey, I; Viteri, S |
|
[中山醫學大學研究成果] 期刊論文 |
2020 |
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma |
Raghav, L; Chang, YH; Hsu, YC; Li, YC; Chen, CY; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Chuang, CY; Lee, MH; Wang, CL; Chen, HW; Yu, SL; Su, SF; Yuan, SS; Chen, JJW; Ho, SY; Li, KC; Yang, PC; Chang, GC; Chen, HY |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Response |
Su, SF; Liu, CH; Cheng, CL; Ho, CC; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Chen, HW; Chang, GC; Yu, SL; Li, KC |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment |
Tseng, JS; Hsu, KH; Zheng, ZR; Yang, TY; Chen, KC; Huang, YH; Su, KY; Yu, SL; Chang, GC |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Paired-like homeodomain 2B contributes to tumour progression and anti-autophagy in human lung cancer |
Wang, CC; Lin, SY; Huang, YH; Hsieh, CH; Chang, HH; Chen, HY; Weng, CW; Chang, GC; Yu, SL; Chen, JJW |
|
[中山醫學大學研究成果] 期刊論文 |
2020 |
Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women |
Wong, JYY; Zhang, H; Hsiung, CA; Shiraishi, K; Yu, K; Matsuo, K; Wong, MP; Hong, YC; Wang, JC; Seow, WJ; Wang, ZM; Song, MS; Kim, HN; Chang, IS; Chatterjee, N; Hu, W; Wu, C; Mitsudomi, T; Zheng, W; Kim, JH; Seow, A; Caporaso, NE; Shin, MH; Chung, LP; An, SJ; Wang, P; Yang, Y; Zheng, H; Yatabe, Y; Zhang, XC; Kim, YT; Cai, QY; Yin, ZH; Kim, YC; Bassig, BA; Chang, J; Ho, JCN; Ji, BT; Daigo, Y; Ito, H; Momozawa, Y; Ashikawa, K; Kamatani, Y; Honda, T; Hosgood, HD; Sakamoto, H; Kunitoh, H; Tsuta, K; Watanabe, SI; Kubo, M; Miyagi, Y; Nakayama, H; Matsumoto, S; Tsuboi, M; Goto, K; Shi, JX; Song, L; Hua, X; Takahashi, A; Goto, A; Minamiya, Y; Shimizu, K; Tanaka, K; Wei, F; Matsuda, F; Su, J; Kim, YH; Oh, IJ; Song, FJ; Su, WC; Chen, YM; Chang, GC; Chen, KY; Huang, MS; Chien, LH; Xiang, YB; Park, JY; Kweon, SS; Chen, CJ; Lee, KM; Blechter, B; Li, HX; Gao, YT; Qian, BY; Lu, DR; Liu, JJ; Jeon, HS; Hsiao, CF; Sung, JS; Tsai, YH; Jung, YJ; Guo, H; Hu, ZB; Wang, WC; Chung, CC; Burdett, L; Yeager, M; Hutchinson, A; Berndt, SI; Wu, W; Pang, H; Li, YQ; Choi, JE; Park, KH; Sung, SW; Liu, L; Kang, CH; Zhu, M; Chen, CH; Yang, TY; Xu, J; Guan, P; Tan, W; Wang, CL; Hsin, M; Sit, KY; Chen, Y; Choi, YY; Hung, JY; Kim, JS; Il Yoon, H; Lin, CC; Park, IK; Xu, P; Wang, Y; He, Q; Perng, RP; Chen, CY; Vermeulen, R; Wu, JJ; Lim, WY; Chen, KC; Li, YJ; Li, JH; Chen, HY; Yu, CJ; Jin, L; Chen, TY; Jiang, SS; Liu, J; Yamaji, T; Hicks, B; Wyatt, K; Li, SA; Dai, JC; Ma, HX; Jin, GF; Song, B; Wang, ZH; Cheng, SS; Li, XL; Ren, YW; Cui, P; Iwasaki, M; Shimazu, T; Tsugane, S; Zhu, JJ; Yang, KY; Jiang, GN; Fei, K; Wu, GP; Lin, HC; Chen, HL; Fang, YH; Tsai, FY; Hsieh, WS; Yu, JM; Stevens, VL; Laird-Offringa, IA; Marconett, CN; Rieswijk, L; Chao, A; Yang, PC; Shu, XO; Wu, T; Wu, YL; Lin, DX; Chen, KX; Zhou, BS; Huang, YC; Kohno, T; Shen, H; Chanock, SJ; Rothman, N; Lan, Q |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
Impact of tumor disappearance ratio on the prognosis of lung adenocarcinoma <= 2 cm in size: A retrospective cohort study |
Wu, JJ; Wu, CY; Wu, CY; Wang, CL; Yang, TY; Tseng, JS; Hsu, KH; Huang, YH; Hsu, CP; Chuang, CY; Lin, CH; Tseng, CH; Chen, KC; Chang, GC |
|
[中山醫學大學研究成果] 期刊論文 |
2021 |
The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer |
Wu, MF; Lin, CA; Yuan, TH; Yeh, HY; Su, SF; Guo, CL; Chang, GC; Li, KC; Ho, CC; Chen, HW |
|
[中山醫學大學研究成果] 期刊論文 |
2020 |
An Observational Study of AcquiredEGFRT790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan |
Wu, SG; Chiang, CL; Liu, CY; Wang, CC; Su, PL; Hsia, TC; Shih, JY; Chang, GC |
|
[醫學研究所] 期刊論文 |
2021-06-08 |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M |
Yen-Hsiang Huang; Jeng-Sen Tseng; Kuo-Hsuan Hsu; Kun-Chieh Chen; Kang-Yi Su; Sung-Liang Yu; Jeremy J. W. Chen; Tsung-Ying Yang; Gee-Chen Chang |
|
[醫學分子毒理學研究所] 博碩士論文 |
2004 |
抗肺癌藥物 (ZD1839,Gemcitabine) 由臨床到基礎進行一系列之作用及分子機轉探討 |
張基晟; Gee-Chen Chang |
|
[醫學研究所] 博碩士論文 |
2001 |
實測法與估算法肌氨酸廓清率在非小細胞肺癌病人接受以順鉑(cisplatin)為主的化學治療之比較 |
張基晟; Gee-Chen Chang |
|
[中山醫訊] 報導 |
2021-08 |
肺癌的診斷與治療 |
張基晟 |
|
[專題研究計畫(教師)] 教師研究計畫 |
2019-07-01 |
年輕型非小細胞肺癌之HLA基因型與癌特定抗原的鑑定與特性分析(二) |
張基晟 |
|
|